Cecile Guyonnet
Overview
Explore the profile of Cecile Guyonnet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Claverie C, Coppolino F, Mazzuoli M, Guyonnet C, Jacquemet E, Legendre R, et al.
Nat Commun
. 2024 Oct;
15(1):9175.
PMID: 39448655
Bacterial two-component systems (TCSs) are signaling modules that control physiology, adaptation, and host interactions. A typical TCS consists of a histidine kinase (HK) that activates a response regulator via phosphorylation...
2.
Micheli G, Parpex G, Tazi A, Holeindre E, Loubinoux J, Guyonnet C, et al.
J Infect
. 2024 Sep;
89(5):106253.
PMID: 39260624
No abstract available.
3.
Brissac T, Guyonnet C, Sadouni A, Hernandez-Montoya A, Jacquemet E, Legendre R, et al.
Microlife
. 2024 Jul;
5:uqae014.
PMID: 38993744
is among the few pathogens that have not developed resistance to ß-lactam antibiotics despite decades of clinical use. The molecular basis of this long-lasting susceptibility has not been investigated, and...
4.
Shalaby A, Benaboud S, Dedieu D, Anjou M, Rasmussen C, Brezin A, et al.
J Antimicrob Chemother
. 2024 Jun;
79(8):2077-2078.
PMID: 38863388
No abstract available.
5.
Sbaa G, Delettre N, Guyonnet C, Le Huu Nghia S, Joubrel-Guyot C, Plainvert C, et al.
J Infect Dis
. 2024 Jun;
231(2):329-333.
PMID: 38842059
Recurrence is a rare complication of group B Streptococcus (GBS) neonatal infections. We conducted a retrospective observational study on GBS neonatal invasive infections in France from 2007 to 2021. A...
6.
Charfi R, Tazi A, Sereme Y, Plainvert C, Poupet H, Doloy A, et al.
J Antimicrob Chemother
. 2024 May;
79(7):1711-1714.
PMID: 38785356
No abstract available.
7.
Charfi R, Guyonnet C, Untrau M, Giacometti G, Paper T, Poyart C, et al.
Ann Clin Microbiol Antimicrob
. 2024 Apr;
23(1):37.
PMID: 38664821
Purpose: Group B Streptococcus (GBS) is the leading cause of invasive infections in newborns. The prevention of GBS neonatal disease relies on the administration of an intrapartum antibiotic prophylaxis to...
8.
Delettre N, Billion E, Guyonnet C, Jarreau P, Patkai J, Tazi A
Acta Paediatr
. 2024 Jan;
113(5):947-954.
PMID: 38183311
Aim: Clusters of group B Streptococcus (GBS) infections in neonatal intensive care units (NICU) are poorly documented. We aimed to assess GBS cross-transmission during an outbreak of GBS sepsis. Methods:...
9.
Maillard A, Micheli G, Lefevre L, Guyonnet C, Poyart C, Canoui E, et al.
Clin Infect Dis
. 2023 Oct;
78(4):825-832.
PMID: 37823416
Background: The development of chatbot artificial intelligence (AI) has raised major questions about their use in healthcare. We assessed the quality and safety of the management suggested by Chat Generative...
10.
Bossuet N, Guyonnet C, Chagneau C, Tang-Fichaux M, Penary M, Loubet D, et al.
Gut Microbes
. 2023 Jun;
15(1):2222437.
PMID: 37312436
Up to 25% of the strains isolated from the feces of healthy humans harbor the genomic island encoding the synthesis of colibactin, a genotoxic metabolite. Evidence is accumulating for an...